Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 24Pancreatic Neoplasms 14Stomach Neoplasms 12Rectal Neoplasms 12Squamous Cell Carcinoma of Head and Neck 9Esophageal Neoplasms 9Colonic Neoplasms 9Neoplasms 7Adenocarcinoma Of Esophagus 7Urinary Bladder Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasm Metastasis 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Breast Neoplasms 4Anus Neoplasms 4Ovarian Neoplasms 3Nasopharyngeal Carcinoma 2Melanoma 2Hepatoblastoma 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Urachal cancer 1Unresectable Colorectal Cancer 1

Interventions

Specimen Handling 4Nivolumab 4avelumab 3pembrolizumab 2cabozantinib 2atezolizumab 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Immunoglobulin G 2Gemcitabine 2Disulfides 2Cisplatin 2CTLA-4 Antigen 2Biopsy 2tremelimumab 1tocilizumab 1relatlimab 1guadecitabine 1eribulin 1erdafitinib 1enfortumab vedotin 1durvalumab 1Propranolol 1Platinum 1Leucovorin 1Fluorouracil 1Etoposide 1Doxorubicin 1Docetaxel 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Urethral Neoplasms × Fluorouracil × Clear all
NCT00082706 2025-09-09

Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
46 enrolled
Genitourinary

Urachal cancer, Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡